MIT Holding, Inc. (OTCBB: MITD) announces it has accepted the resignation of John Sabia as CFO and Board Member for MIT. Mr. Sabia will continue to work for the company in other assigned areas already under his direction. MIT Holding, Inc.’s newly elected Co-Chairman and Co-President, Walter H.C. Drakeford is named as the new CFO and Director on the board issued the following statement, “MIT Holding, Inc. is very grateful for Mr. Sabia’s commitment to the company and his continued service to other important areas he is currently assigned to.” MIT’s Co-Chairman and Co-President, William Parker adds, “John’s presence is an important part of MIT’s management team and continues to be a vital asset to MIT’s total commitment to the entire family of MIT companies.”

About MIT Holding, Inc.

MIT Holding, Inc. (MIT) is a holding company. The Company, through its three wholly owned subsidiaries, distributes wholesale pharmaceuticals, administers intravenous infusions, operates an ambulatory center where therapies are administered, and sells and rents home medical equipment. The Company’s subsidiaries include MIT International Distribution, Inc. (MIT International), Medical Infusion Technologies, Inc. (Infusion), and MIT Ambulatory Care Center, Inc. (Ambulatory). The Company has four principal operating segments: Medical Infusion Technologies (MIT), MIT Wholesale (Wholesale), Durable Medical Equipment (DME) and MIT Ambulatory Care Center (Ambulatory Care). More information can be found at www.mitholdinginc.com.

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements, including, but not limited to, statements regarding MIT's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in MIT's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. MIT undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.